Axa S.A. West Pharmaceutical Services Inc Transaction History

Axa S.A.

$32.3 Billion
Q3 2024

A detailed history of Axa S.A. transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Axa S.A. holds 1,074 shares of WST stock, worth $362,152. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,074

Previous 17,949 94.02%

Holding current value

$362,152

Previous $5.91 Million 94.55%

% of portfolio

0.0%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$277.16 - $333.3 $4.68 Million - $5.62 Million	-16,875 Reduced 94.02%	1,074 $322,000
Q2 2024 Aug 14, 2024	BUY	$314.68 - $395.94 $618,031 - $777,626	1,964 Added 12.29%	17,949 $5.91 Million
Q1 2024 May 15, 2024	SELL	$338.27 - $413.0 $2.25 Million - $2.75 Million	-6,657 Reduced 29.4%	15,985 $6.33 Million
Q4 2023 Jul 16, 2024	BUY	$318.29 - $392.21 $2.12 Million - $2.61 Million	6,657 Added 41.65%	22,642 $7.97 Million
Q4 2023 Feb 14, 2024	SELL	$318.29 - $392.21 $7.03 Million - $8.66 Million	-22,075 Reduced 49.37%	22,642 $7.97 Million
Q3 2023 Nov 14, 2023	SELL	$354.9 - $412.41 $7.13 Million - $8.28 Million	-20,077 Reduced 30.99%	44,717 $16.8 Million
Q2 2023 Aug 14, 2023	BUY	$334.63 - $382.47 $6.48 Million - $7.41 Million	19,370 Added 42.64%	64,794 $24.8 Million
Q1 2023 May 15, 2023	SELL	$232.5 - $346.47 $23.2 Million - $34.6 Million	-99,871 Reduced 68.74%	45,424 $15.7 Million
Q4 2022 Feb 14, 2023	BUY	$209.34 - $261.61 $20.9 Million - $26.2 Million	99,969 Added 220.56%	145,295 $34.2 Million
Q3 2022 Feb 14, 2023	SELL	$246.08 - $343.65 $17.9 Million - $25 Million	-72,706 Reduced 61.6%	45,326 $11.2 Million
Q3 2022 Nov 14, 2022	SELL	$246.08 - $343.65 $17.9 Million - $25 Million	-72,706 Reduced 61.6%	45,326 $11.2 Million
Q2 2022 Feb 14, 2023	SELL	$280.61 - $420.45 $6.06 Million - $9.08 Million	-21,589 Reduced 15.46%	118,032 $35.7 Million
Q2 2022 Aug 15, 2022	SELL	$280.61 - $420.45 $6.06 Million - $9.08 Million	-21,589 Reduced 15.46%	118,032 $35.7 Million
Q1 2022 Feb 14, 2023	BUY	$357.49 - $445.92 $33.7 Million - $42 Million	94,295 Added 208.04%	139,621 $57.3 Million
Q1 2022 May 13, 2022	SELL	$357.49 - $445.92 $7.75 Million - $9.67 Million	-21,689 Reduced 13.45%	139,621 $57.3 Million
Q4 2021 Feb 14, 2022	BUY	$402.25 - $471.34 $19.3 Million - $22.6 Million	47,985 Added 42.34%	161,310 $75.7 Million
Q3 2021 Nov 15, 2021	SELL	$363.01 - $468.47 $24.5 Million - $31.6 Million	-67,553 Reduced 37.35%	113,325 $48.1 Million
Q2 2021 Aug 13, 2021	BUY	$284.77 - $363.2 $19.1 Million - $24.3 Million	66,993 Added 58.83%	180,878 $65 Million
Q1 2021 May 14, 2021	SELL	$257.29 - $307.53 $2.05 Million - $2.45 Million	-7,953 Reduced 6.53%	113,885 $32.1 Million
Q4 2020 Feb 12, 2021	BUY	$261.16 - $301.66 $14.8 Million - $17.1 Million	56,549 Added 86.61%	121,838 $34.5 Million
Q3 2020 Nov 13, 2020	SELL	$224.99 - $288.02 $8.05 Million - $10.3 Million	-35,799 Reduced 35.41%	65,289 $17.9 Million
Q2 2020 Aug 14, 2020	BUY	$149.8 - $227.17 $4.69 Million - $7.11 Million	31,288 Added 44.83%	101,088 $23 Million
Q1 2020 May 15, 2020	BUY	$128.96 - $174.76 $7.08 Million - $9.59 Million	54,900 Added 368.46%	69,800 $10.6 Million
Q4 2019 Feb 18, 2020	BUY	$137.6 - $151.21 $2.05 Million - $2.25 Million	14,900 New	14,900 $2.24 Million

Others Institutions Holding WST

# of Institutions

804

Shares Held

64.9M

Call Options Held

294K

Put Options Held

490K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $25B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account